CCL2 and metabolic syndrome: When most of the Treg cells were ablated, pro-inflammatory transcripts (e.g., RANTES and CCL2) were strongly induced in the fat tissue, suggesting that the anti-inflammatory properties of Treg cells may have therapeutic potential to inhibit elements of the metabolic syndrome [34].